We understand why some are so focused on non irrelevant web sites and baby sitter aussies. It makes sense that discussing current sales of onko-Sure and reverse merger discussions is not part of ones agenda, and diverting to silly web sites is just that , a distraction from the facts..William will be selling the colon test along with the lung cancer test, similiar to Mode....Radient Pharma will resurrect into a low cost cancer test, count them 13...plus you understand. All 5 billion sharess of RXPC are held on tightly, waiting on the sidelines....Low cost cancer tests is the initiative... Radient iunderstands low cost tests...Mode at 39 dollars and Onko-Sure 99 dollars...Compared to Exact Science. 800 dollar test..Time to sell....Sorry EXAS Dudes...lol
Cheap, Fast, Accurate Home Colon Cancer Test Joins Growing List of Diagnostic Tests Shifting from Medical Laboratories to Homes
Home Test Promises Same Accuracy as Clinical Laboratory Test
That’s the goal of Mode Diagnostics, Ltd., a Scottish company that is poised to sell a consumer device that can detect signs of colon cancer at home in three minutes at an accuracy rate of 98%. Mode’s new device is an example of how innovative diagnostic technology is driving the market for fast, accurate consumer self-test kits—and pushing these tests out of the central clinical laboratory and into the home.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.